Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-06-03 Sale |
2022-06-06 5:40 pm |
Karyopharm Therapeutics Inc. | KPTI | Mason Michael EVP, CFO, Treasurer |
601 | $6.0401 | $3,630 | 138,509 (Direct) |
View |
| 2022-05-04 Sale |
2022-05-05 4:08 pm |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
28,502 | $6.228 | $177,509 | 633,448 (Direct) |
View |
| 2022-02-28 Sale |
2022-03-02 3:34 pm |
Karyopharm Therapeutics Inc. | KPTI | Frenkel Ran EVP, Chief Dev. Officer |
1,663 | $10.24 | $17,025 | 258,290 (Direct) |
View |
| 2022-02-28 Sale |
2022-03-02 3:33 pm |
Karyopharm Therapeutics Inc. | KPTI | Mason Michael EVP, CFO & Treasurer |
2,398 | $10.24 | $24,550 | 250,710 (Direct) |
View |
| 2022-02-28 Sale |
2022-03-02 3:20 pm |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon Chief Scientific Officer |
12,452 | $10.24 | $127,477 | 1,638,888 (Indirect Direct) |
View |
| 2022-02-28 Sale |
2022-03-02 3:18 pm |
Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Director |
12,452 | $10.24 | $127,477 | 1,638,888 (Indirect Direct) |
View |
| 2022-02-17 Sale |
2022-02-22 4:19 pm |
Karyopharm Therapeutics Inc. | KPTI | Shah Jatin EVP, Chief Medical Officer |
1,306 | $12.12 | $15,833 | 129,450 (Direct) |
View |
| 2022-02-17 Sale |
2022-02-22 4:16 pm |
Karyopharm Therapeutics Inc. | KPTI | Frenkel Ran EVP, Chief Dev. Officer |
2,929 | $12.12 | $35,509 | 101,703 (Direct) |
View |
| 2022-02-17 Sale |
2022-02-22 4:15 pm |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon Chief Scientific Officer |
18,167 | $12.12 | $220,246 | 1,603,340 (Indirect Direct) |
View |
| 2022-02-17 Sale |
2022-02-22 4:14 pm |
Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Director |
18,167 | $12.12 | $220,246 | 1,603,340 (Indirect Direct) |
View |
| 2022-02-07 Sale |
2022-02-09 5:27 pm |
Karyopharm Therapeutics Inc. | KPTI | Shah Jatin EVP, Chief Medical Officer |
1,704 | $9.862 | $16,805 | 130,756 (Direct) |
View |
| 2022-02-07 Sale |
2022-02-09 5:26 pm |
Karyopharm Therapeutics Inc. | KPTI | Frenkel Ran EVP, Chief Dev. Officer |
1,991 | $9.862 | $19,635 | 104,632 (Direct) |
View |
| 2022-02-07 Sale |
2022-02-09 5:25 pm |
Karyopharm Therapeutics Inc. | KPTI | Mason Michael EVP, CFO & Treasurer |
3,947 | $9.862 | $38,925 | 53,308 (Direct) |
View |
| 2022-02-07 Sale |
2022-02-09 5:24 pm |
Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Director |
13,471 | $9.862 | $132,851 | 1,621,507 (Indirect Direct) |
View |
| 2022-02-07 Sale |
2022-02-09 5:22 pm |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon Chief Scientific Officer |
13,471 | $9.862 | $132,851 | 1,621,507 (Indirect Direct) |
View |
| 2021-12-02 Sale |
2021-12-03 6:17 pm |
Karyopharm Therapeutics Inc. | KPTI | Mitchener Stephen SVP, Chief Business Officer |
499 | $6.69 | $3,338 | 3,296 (Direct) |
View |
| 2021-06-02 Sale |
2021-06-03 4:06 pm |
Karyopharm Therapeutics Inc. | KPTI | Mitchener Stephen SVP, Chief Business Officer |
528 | $9.29 | $4,905 | 2,472 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-05-19 Option Award |
2022-05-20 4:12 pm |
N/A 2032-05-18 |
Karyopharm Therapeutics Inc. | KPTI | Schor Chen Director |
23,900 | $0 | 23,900 (Direct) |
View |
| 2022-05-19 Option Award |
2022-05-20 4:11 pm |
N/A 2032-05-18 |
Karyopharm Therapeutics Inc. | KPTI | PAKIANATHAN DEEPIKA Director |
23,900 | $0 | 23,900 (Direct) |
View |
| 2022-05-19 Option Award |
2022-05-20 4:09 pm |
N/A 2032-05-18 |
Karyopharm Therapeutics Inc. | KPTI | Oliger Christy J. Director |
23,900 | $0 | 23,900 (Direct) |
View |
| 2022-05-19 Option Award |
2022-05-20 4:07 pm |
N/A 2032-05-18 |
Karyopharm Therapeutics Inc. | KPTI | Mirza Mansoor Raza Director |
23,900 | $0 | 23,900 (Direct) |
View |
| 2022-05-19 Option Award |
2022-05-20 4:06 pm |
N/A 2032-05-18 |
Karyopharm Therapeutics Inc. | KPTI | Honig Peter Director |
10,995 | $0 | 10,995 (Direct) |
View |
| 2022-05-19 Option Award |
2022-05-20 4:03 pm |
N/A 2032-05-18 |
Karyopharm Therapeutics Inc. | KPTI | BOHLIN GAREN G Director |
23,900 | $0 | 23,900 (Direct) |
View |
| 2022-05-19 Option Award |
2022-05-20 4:02 pm |
N/A 2032-05-18 |
Karyopharm Therapeutics Inc. | KPTI | Greene Barry E Director |
23,900 | $0 | 23,900 (Direct) |
View |
| 2022-04-29 Option Award |
2022-05-02 5:01 pm |
N/A 2032-04-28 |
Karyopharm Therapeutics Inc. | KPTI | Rangwala Reshma EVP & Chief Medical Officer |
165,000 | $0 | 165,000 (Direct) |
View |
| 2022-03-29 Option Award |
2022-03-31 4:17 pm |
N/A 2032-03-28 |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon Chief Scientific Officer |
150,000 | $0 | 1,761,888 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 3:34 pm |
N/A 2032-02-27 |
Karyopharm Therapeutics Inc. | KPTI | Frenkel Ran EVP, Chief Dev. Officer |
158,250 | $0 | 258,290 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 3:33 pm |
N/A 2032-02-27 |
Karyopharm Therapeutics Inc. | KPTI | Mason Michael EVP, CFO & Treasurer |
199,800 | $0 | 250,710 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 3:20 pm |
N/A 2032-02-27 |
Karyopharm Therapeutics Inc. | KPTI | Shacham Sharon Chief Scientific Officer |
48,000 | $0 | 1,638,888 (Indirect) |
View |
| 2022-02-28 Option Award |
2022-03-02 3:18 pm |
N/A 2032-02-27 |
Karyopharm Therapeutics Inc. | KPTI | Kauffman Michael Director |
48,000 | $0 | 1,638,888 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 3:15 pm |
N/A 2032-02-27 |
Karyopharm Therapeutics Inc. | KPTI | Mitchener Stephen SVP, Chief Business Officer |
106,650 | $0 | 109,946 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 3:15 pm |
N/A 2032-02-27 |
Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan Chief Commercial Officer |
192,000 | $0 | 199,500 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 3:14 pm |
N/A 2032-02-27 |
Karyopharm Therapeutics Inc. | KPTI | Paulson Richard A. President and CEO |
648,750 | $0 | 1,021,950 (Direct) |
View |
| 2022-02-28 Option Award |
2022-03-02 3:14 pm |
N/A 2032-02-27 |
Karyopharm Therapeutics Inc. | KPTI | Mano Michael SVP, General Counsel&Secretary |
144,000 | $0 | 144,000 (Direct) |
View |
| 2021-12-03 Option Award |
2021-12-07 10:37 am |
N/A 2031-12-02 |
Karyopharm Therapeutics Inc. | KPTI | Honig Peter Director |
47,800 | $0 | 47,800 (Direct) |
View |
| 2021-07-12 Tax Withholding |
2021-07-13 6:21 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Shah Jatin EVP, Chief Medical Officer |
665 | $9.73 | 131,137 (Direct) |
View |
| 2021-06-30 Option Award |
2021-07-01 4:33 pm |
N/A 2031-06-29 |
Karyopharm Therapeutics Inc. | KPTI | Cheng Sohanya Roshan SVP Sales & Commercial Ops |
132,500 | $0 | 132,500 (Direct) |
View |
| 2021-06-01 Option Award |
2021-06-01 5:53 pm |
N/A 2031-05-31 |
Karyopharm Therapeutics Inc. | KPTI | Mason Michael EVP, CFO, Treasurer |
20,500 | $0 | 72,255 (Direct) |
View |
| 2021-05-30 Exercise |
2021-06-01 4:05 pm |
N/A N/A |
Karyopharm Therapeutics Inc. | KPTI | Mitchener Stephen SVP, Chief Business Officer |
1,500 | $0 | 4,500 (Direct) |
View |
| 2021-05-21 Option Award |
2021-05-21 5:36 pm |
N/A 2031-05-20 |
Karyopharm Therapeutics Inc. | KPTI | Schor Chen Director |
23,900 | $0 | 23,900 (Direct) |
View |
| 2021-05-21 Option Award |
2021-05-21 5:35 pm |
N/A 2031-05-20 |
Karyopharm Therapeutics Inc. | KPTI | PAKIANATHAN DEEPIKA Director |
23,900 | $0 | 23,900 (Direct) |
View |